• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌肝转移

Hepatic Metastasis from Breast Cancer.

作者信息

Liberchuk Ariel N, Deipolyi Amy R

机构信息

Interventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.

出版信息

Semin Intervent Radiol. 2020 Dec;37(5):518-526. doi: 10.1055/s-0040-1720949. Epub 2020 Dec 11.

DOI:10.1055/s-0040-1720949
PMID:33328708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7732569/
Abstract

Breast cancer is the most common cancer in women and breast cancer liver metastasis may be associated with poor outcomes. Emerging locoregional therapies can be given in outpatient settings or with short hospital stays, to provide local control, support quality of life, preserve liver function, and potentially prolong survival. This review discusses retrospective studies suggesting potential benefits of locoregional treatment of breast cancer liver metastasis. Future prospective studies are needed to demonstrate efficacy and optimize patient selection.

摘要

乳腺癌是女性中最常见的癌症,乳腺癌肝转移可能与不良预后相关。新出现的局部区域疗法可以在门诊环境中进行,或只需短暂住院,以实现局部控制、支持生活质量、保护肝功能并有可能延长生存期。本综述讨论了回顾性研究,这些研究提示了乳腺癌肝转移局部区域治疗的潜在益处。未来需要进行前瞻性研究以证明疗效并优化患者选择。

相似文献

1
Hepatic Metastasis from Breast Cancer.乳腺癌肝转移
Semin Intervent Radiol. 2020 Dec;37(5):518-526. doi: 10.1055/s-0040-1720949. Epub 2020 Dec 11.
2
Locoregional Therapies for the Treatment of Hepatic Metastases from Breast and Gynecologic Cancers.用于治疗乳腺癌和妇科癌症肝转移的局部区域疗法。
Semin Intervent Radiol. 2018 Mar;35(1):29-34. doi: 10.1055/s-0038-1636518. Epub 2018 Apr 5.
3
Metastatic disease to the liver: Locoregional therapy strategies and outcomes.肝脏转移性疾病:局部区域治疗策略与疗效
World J Clin Oncol. 2021 Sep 24;12(9):725-745. doi: 10.5306/wjco.v12.i9.725.
4
Liver-dominant Breast Cancer Metastasis: A Comparative Outcomes Study of Chemoembolization Radioembolization.肝转移为主的乳腺癌:化疗栓塞与放射性栓塞的疗效对比研究
Anticancer Res. 2018 May;38(5):3063-3068. doi: 10.21873/anticanres.12563.
5
Locoregional Therapies of Cholangiocarcinoma.胆管癌的局部区域治疗
Visc Med. 2016 Dec;32(6):414-420. doi: 10.1159/000453010. Epub 2016 Dec 5.
6
Locoregional Therapies for the Treatment of Uveal Melanoma Hepatic Metastases.用于治疗葡萄膜黑色素瘤肝转移的局部区域疗法。
Semin Intervent Radiol. 2020 Dec;37(5):508-517. doi: 10.1055/s-0040-1720948. Epub 2020 Dec 11.
7
Local Treatment of Breast Cancer Liver Metastasis.乳腺癌肝转移的局部治疗
Cancers (Basel). 2019 Sep 11;11(9):1341. doi: 10.3390/cancers11091341.
8
Management of liver dominant metastatic breast cancer: surgery, chemotherapy, or hepatic arterial therapy - benefits and limitations.肝转移为主的转移性乳腺癌的治疗:手术、化疗或肝动脉治疗——益处与局限性
Minerva Chir. 2012 Aug;67(4):297-308.
9
Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality.肝细胞癌经动脉化疗栓塞与经动脉放射性栓塞治疗:治疗方式选择的优化
Hepatol Int. 2016 Nov;10(6):883-892. doi: 10.1007/s12072-016-9722-9. Epub 2016 Apr 28.
10
Yttrium-90 radioembolization for unresectable hepatic metastases of breast cancer: A systematic review.钇-90放射性栓塞治疗不可切除的乳腺癌肝转移:一项系统评价。
World J Gastrointest Oncol. 2020 Feb 15;12(2):228-236. doi: 10.4251/wjgo.v12.i2.228.

引用本文的文献

1
Reshaping the landscape of locoregional treatments for breast cancer liver metastases: A novel, intratumoral, p21-targeted percutaneous therapy increases survival in BALB/c mice inoculated with 4T1 triple negative breast cancer cells in the liver.重塑乳腺癌肝转移局部区域治疗格局:一种新型的、肿瘤内靶向p21的经皮治疗可提高接种4T1三阴性乳腺癌细胞的BALB/c小鼠的生存率。
PLoS One. 2025 Jun 5;20(6):e0323621. doi: 10.1371/journal.pone.0323621. eCollection 2025.
2
Role of Interventional Radiology in Managing Primary and Metastatic Breast Cancer.介入放射学在原发性和转移性乳腺癌治疗中的作用
Semin Intervent Radiol. 2024 Jul 10;41(2):129-134. doi: 10.1055/s-0044-1786730. eCollection 2024 Apr.
3
Different risk and prognostic factors for liver metastasis of breast cancer patients with and relapsed distant metastasis in a Chinese population.中国人群中伴有和复发远处转移的乳腺癌患者肝转移的不同风险和预后因素。
Front Oncol. 2023 Apr 14;13:1102853. doi: 10.3389/fonc.2023.1102853. eCollection 2023.
4
Prospective Evaluation of Immune Activation Associated with Response to Radioembolization Assessed with PET/CT in Women with Breast Cancer Liver Metastasis.前瞻性评估乳腺癌肝转移患者经 PET/CT 评估的与放射栓塞治疗反应相关的免疫激活。
Radiology. 2023 Jan;306(1):279-287. doi: 10.1148/radiol.220158. Epub 2022 Aug 16.
5
Transarterial Yttrium-90 Glass Microsphere Radioembolization of Chemotherapy-Refractory Breast Cancer Liver Metastases: Results of a Single Institution Retrospective Study.经动脉钇-90玻璃微球放射性栓塞治疗化疗难治性乳腺癌肝转移:单机构回顾性研究结果
Adv Radiat Oncol. 2021 Oct 29;7(1):100838. doi: 10.1016/j.adro.2021.100838. eCollection 2022 Jan-Feb.
6
Metastatic disease to the liver: Locoregional therapy strategies and outcomes.肝脏转移性疾病:局部区域治疗策略与疗效
World J Clin Oncol. 2021 Sep 24;12(9):725-745. doi: 10.5306/wjco.v12.i9.725.
7
Radioembolization of Secondary Hepatic Malignancies.继发性肝恶性肿瘤的放射性栓塞治疗
Semin Intervent Radiol. 2021 Oct;38(4):445-452. doi: 10.1055/s-0041-1732318. Epub 2021 Oct 7.

本文引用的文献

1
Predictors of Progression-Free Survival and Local Tumor Control after Percutaneous Thermal Ablation of Oligometastatic Breast Cancer: Retrospective Study.寡转移性乳腺癌经皮热消融术后无进展生存期和局部肿瘤控制的预测因素:回顾性研究
J Vasc Interv Radiol. 2020 Aug;31(8):1201-1209. doi: 10.1016/j.jvir.2020.02.016. Epub 2020 Jul 19.
2
Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers.新辅助免疫治疗导致 MMR 功能正常和 MMR 缺陷的早期结肠癌发生病理应答。
Nat Med. 2020 Apr;26(4):566-576. doi: 10.1038/s41591-020-0805-8. Epub 2020 Apr 6.
3
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer.恩美曲妥珠单抗治疗既往 HER2 阳性乳腺癌。
N Engl J Med. 2020 Feb 13;382(7):610-621. doi: 10.1056/NEJMoa1914510. Epub 2019 Dec 11.
4
PET/CT Imaging Characteristics After Radioembolization of Hepatic Metastasis from Breast Cancer.乳腺癌肝转移放射性栓塞治疗后 PET/CT 影像学特征。
Cardiovasc Intervent Radiol. 2020 Mar;43(3):488-494. doi: 10.1007/s00270-019-02375-7. Epub 2019 Nov 15.
5
Local Treatment of Breast Cancer Liver Metastasis.乳腺癌肝转移的局部治疗
Cancers (Basel). 2019 Sep 11;11(9):1341. doi: 10.3390/cancers11091341.
6
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.寡转移癌症患者立体定向消融放疗与标准姑息治疗的比较(SABR-COMET):一项随机、2 期、开放标签试验。
Lancet. 2019 May 18;393(10185):2051-2058. doi: 10.1016/S0140-6736(18)32487-5. Epub 2019 Apr 11.
7
Breast Cancer Treatment: A Review.乳腺癌治疗:综述。
JAMA. 2019 Jan 22;321(3):288-300. doi: 10.1001/jama.2018.19323.
8
Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy.立体定向体部放疗治疗乳腺癌肝转移的疗效观察。
Breast. 2018 Dec;42:150-156. doi: 10.1016/j.breast.2018.09.006. Epub 2018 Sep 29.
9
Long-term outcomes and prognostic analysis of percutaneous radiofrequency ablation in liver metastasis from breast cancer.乳腺癌肝转移经皮射频消融治疗的长期疗效及预后分析。
Int J Hyperthermia. 2019 Jan 1;35(1):183-193. doi: 10.1080/02656736.2018.1488279. Epub 2018 Sep 10.
10
Association of PI3K Pathway Mutations with Early Positron-Emission Tomography/CT Imaging Response after Radioembolization for Breast Cancer Liver Metastases: Results of a Single-Center Retrospective Pilot Study.PI3K通路突变与乳腺癌肝转移放射性栓塞后早期正电子发射断层扫描/计算机断层扫描成像反应的相关性:一项单中心回顾性初步研究结果
J Vasc Interv Radiol. 2018 Sep;29(9):1226-1235. doi: 10.1016/j.jvir.2018.04.018. Epub 2018 Aug 3.